lithium has been researched along with Retinal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akula, JD; Chen, J; Favazza, TL; Fredrick, TW; Gong, Y; He, X; Liu, CH; Morss, PC; Saba, NJ; Sun, Y; Wang, Z | 1 |
| Graw, P; Heinen, U; Prünte, A; Remé, C; Urner, U; Wirz-Justice, A | 1 |
| Doly, M; Droy-Lefaix, MT; Jung, H; Munz, K; Remé, C; Wei, Q | 1 |
1 trial(s) available for lithium and Retinal Diseases
| Article | Year |
|---|---|
Lithium decreases retinal sensitivity, but this is not cumulative with years of treatment.
Topics: Adult; Aged; Aged, 80 and over; Antimanic Agents; Bipolar Disorder; Color Perception; Dark Adaptation; Female; Humans; Lithium; Male; Middle Aged; Retinal Diseases | 1997 |
2 other study(ies) available for lithium and Retinal Diseases
| Article | Year |
|---|---|
Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy.
Topics: Animals; Disease Models, Animal; Eye Diseases, Hereditary; Familial Exudative Vitreoretinopathies; Female; Humans; Lithium; Low Density Lipoprotein Receptor-Related Protein-5; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Retina; Retinal Diseases; Retinal Vessels; Vascular Endothelial Growth Factor A; Wnt Signaling Pathway | 2016 |
Light and lithium effects in the rat retina: modification by the PAF antagonist BN 52021.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Ginkgolides; Image Processing, Computer-Assisted; Lactones; Light; Lithium; Male; Phagosomes; Platelet Activating Factor; Rats; Retina; Retinal Diseases; Rod Cell Outer Segment | 1992 |